INmune Bio, Quantum Computing Team Up to Identify New Uses for Alzheimer's Drug

09:15 AM EDT, 10/14/2026 (MT Newswires) -- INmune Bio (INMB) and Quantum Computing (QUBT) said Wednesday that they will use quantum computing, artificial intelligence and data analytics to identify new potential applications for INmune's experimental Alzheimer's drug XPro. The companies said they will analyze clinical and biological data to identify diseases that share the same underlying causes targeted by XPro, with an initial focus on rare diseases. Financial details of the collaboration were not disclosed.